Artigos de revistas sobre o tema "SCD89"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "SCD89".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Berthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza et al. "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors". Journal of Experimental Medicine 209, n.º 4 (26 de março de 2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Texto completo da fonteWu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang e Ruitong Gao. "Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History". Disease Markers 2020 (16 de janeiro de 2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
Texto completo da fontevan Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha e Cees van Kooten. "Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89". Journal of Immunology 163, n.º 11 (1 de dezembro de 1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Texto completo da fonteDi Leo, Vincenzo, Patrick J. Gleeson, Fabio Sallustio, Carine Bounaix, Jennifer Da Silva, Gesualdo Loreto, Sanae Ben Mkaddem e Renato C. Monteiro. "Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model". Journal of Personalized Medicine 11, n.º 4 (16 de abril de 2021): 309. http://dx.doi.org/10.3390/jpm11040309.
Texto completo da fonteEsteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey e Eva Mª Martínez Cáceres. "Immunological Pattern in IgA Nephropathy". International Journal of Molecular Sciences 21, n.º 4 (18 de fevereiro de 2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Texto completo da fonteZych, Michał, Aleksander Roszczyk, Filip Dąbrowski, Monika Kniotek e Radosław Zagożdżon. "Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss—A Preliminary Study". International Journal of Molecular Sciences 25, n.º 1 (29 de dezembro de 2023): 499. http://dx.doi.org/10.3390/ijms25010499.
Texto completo da fonteLiu, Chao, Xiaohui Li, Aijie Li, Wenxue Zou, Rui Huang, Xiaoyu Hu, Jinming Yu, Xiaoling Zhang e Jinbo Yue. "Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer". Journal of Immunology Research 2022 (4 de abril de 2022): 1–8. http://dx.doi.org/10.1155/2022/9621466.
Texto completo da fonteOdagiri, Naoshi, Hoang Hai, Le Thi Thanh Thuy, Minh Phuong Dong, Maito Suoh, Kohei Kotani, Atsushi Hagihara et al. "Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization". Cancers 12, n.º 8 (24 de julho de 2020): 2045. http://dx.doi.org/10.3390/cancers12082045.
Texto completo da fonteKAKOULIDOU, M., X. WANG, X. ZHAO, R. PIRSKANEN e A. LEFVERT. "Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis". Journal of Neuroimmunology 185, n.º 1-2 (abril de 2007): 150–61. http://dx.doi.org/10.1016/j.jneuroim.2007.01.007.
Texto completo da fonteLin, Wei. "sCD83 alleviates experimental autoimmune uveitis through disrupting the regulation of Rab1a/LRRK2 on F-actin rearrangements". Journal of Immunology 202, n.º 1_Supplement (1 de maio de 2019): 116.2. http://dx.doi.org/10.4049/jimmunol.202.supp.116.2.
Texto completo da fonteZelek, Wioleta M., Lewis M. Watkins, Owain W. Howell, Rhian Evans, Sam Loveless, Neil P. Robertson, Marijke Beenes, Loek Willems, Ricardo Brandwijk e B. Paul Morgan. "Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59". Multiple Sclerosis Journal 25, n.º 4 (9 de fevereiro de 2018): 523–31. http://dx.doi.org/10.1177/1352458518758927.
Texto completo da fonteKang, Seon Mee, Jun Choul Lee e Bon Jeong Ku. "Changes in Soluble Serum CD81 Concentration during an Oral Glucose Tolerance Test in Patients with Diabetes Mellitus and Individuals with Normal Glucose Tolerance". Diagnostics 13, n.º 23 (21 de novembro de 2023): 3500. http://dx.doi.org/10.3390/diagnostics13233500.
Texto completo da fonteLiu, Shen, Chaoqun Huang, Dawei Li, Weihua Ren, Haoxing Zhang, Meiyan Qi, Xin Li e Long Yu. "Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9." Acta Biochimica Polonica 54, n.º 1 (20 de fevereiro de 2007): 213–18. http://dx.doi.org/10.18388/abp.2007_3289.
Texto completo da fonteEinenkel, Rebekka, Katrin Regina Helene Packhäuser, Jens Ehrhardt, Anne Tüngler, Marek Zygmunt e Damián Oscar Muzzio. "CD83 is locally regulated and differentially expressed in disturbed murine pregnancy". Reproduction 158, n.º 4 (outubro de 2019): 323–33. http://dx.doi.org/10.1530/rep-19-0171.
Texto completo da fonteLinker-Israeli, M., S. Hyun, T. Ozeri-Chen, D. J. Wallace, K. Banks e J. R. Klinenberg. "Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus." Journal of Immunology 152, n.º 6 (15 de março de 1994): 3158–67. http://dx.doi.org/10.4049/jimmunol.152.6.3158.
Texto completo da fonteGong, Xingyu, Tianyi Ma, Qiaoya Zhang, Yanhong Wang, Chengchuang Song, Min Lai, Chunlei Zhang, Xingtang Fang e Xi Chen. "Porcine Reproductive and Respiratory Syndrome Virus Modulates the Switch of Macrophage Polarization from M1 to M2 by Upregulating MoDC-Released sCD83". Viruses 15, n.º 3 (17 de março de 2023): 773. http://dx.doi.org/10.3390/v15030773.
Texto completo da fonteIshibashi, Mariko, Ryosuke Kinoshita, Koiti Inokuchi, Hiroshi Handa, Makoto Sasaki, Norio Komatsu, Yoichi Imai et al. "Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression". Blood 134, Supplement_1 (13 de novembro de 2019): 4361. http://dx.doi.org/10.1182/blood-2019-124635.
Texto completo da fonteMuñiz, Carmen, Lourdes Martín-Martín, Antonio López, Blanca Sánchez-González, Antonio Salar, Julia Almeida, Juan-Manuel Sancho et al. "Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome". Blood 123, n.º 12 (20 de março de 2014): 1864–69. http://dx.doi.org/10.1182/blood-2013-11-537993.
Texto completo da fonteHo, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers e W. Hunstein. "Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia". Blood 75, n.º 5 (1 de março de 1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.bloodjournal7551119.
Texto completo da fonteHo, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers e W. Hunstein. "Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia". Blood 75, n.º 5 (1 de março de 1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.1119.
Texto completo da fonteLundell, Anna-Carin, Kerstin Andersson, Elisabet Josefsson, Alexander Steinkasserer e Anna Rudin. "Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation". Infection and Immunity 75, n.º 8 (25 de maio de 2007): 4097–104. http://dx.doi.org/10.1128/iai.01744-06.
Texto completo da fonteKogure, T., T. Itoh, Y. Shimada, T. Shintani, H. Ochiai e K. Terasawa. "Detection of serum soluble markers of immune activation in rheumatoid arthritis". Mediators of Inflammation 5, n.º 4 (1996): 262–65. http://dx.doi.org/10.1155/s0962935196000373.
Texto completo da fonteOlszewski, Jurek, Wiesław Chudzik, Kazimierz Wiśniewski, Jarosław Miłonski e Robert Matyja. "An Assessment of Concentrations of Soluble CD4 and CD8 Receptors in Serum before and after Surgical Treatment in Patients with Chronic Maxillary Sinusitis". American Journal of Rhinology 17, n.º 3 (maio de 2003): 123–26. http://dx.doi.org/10.1177/194589240301700301.
Texto completo da fontePeckert-Maier, Katrin, Dmytro Royzman, Pia Langguth, Anita Marosan, Astrid Strack, Atefeh Sadeghi Shermeh, Alexander Steinkasserer, Elisabeth Zinser e Andreas B. Wild. "Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation". International Journal of Molecular Sciences 23, n.º 2 (10 de janeiro de 2022): 732. http://dx.doi.org/10.3390/ijms23020732.
Texto completo da fonteKubysheva, Nailya, Larisa Postnikova, Svetlana Soodaeva, Viкtor Novikov, Tatyana Eliseeva, Ildar Batyrshin, Timur Li, Igor Klimanov e Alexander Chuchalin. "Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients". Disease Markers 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/8216723.
Texto completo da fonteYin, Xin-Ke, Chao Wang, Li-Li Feng, Shao-Mei Bai, Wei-Xing Feng, Neng-Tai Ouyang, Zhong-Hua Chu, Xin-Juan Fan e Qi-Yuan Qin. "Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy". Cancers 14, n.º 22 (14 de novembro de 2022): 5573. http://dx.doi.org/10.3390/cancers14225573.
Texto completo da fonteMoretti, Edgardo, Beatriz Basso, Liliana Cervetta, Ana Brigada e Gustavo Barbieri. "Patterns of Cytokines and Soluble Cellular Receptors in the Sera of Children with Acute Chagas' Disease". Clinical and Vaccine Immunology 9, n.º 6 (novembro de 2002): 1324–27. http://dx.doi.org/10.1128/cdli.9.6.1324-1327.2002.
Texto completo da fonteJiang, Chun-Xuan. "THE PRIME PRINCIPLE IN CLUSTERS AND NANOSTRUCTURES". Algebras Groups and Geometries 39, n.º 2 (1 de dezembro de 2023): 189–95. http://dx.doi.org/10.29083/agg.39.02.2023/sc189.
Texto completo da fonteHo, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck e RE Corringham. "Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation". Blood 84, n.º 10 (15 de novembro de 1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.3550.
Texto completo da fonteHo, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck e RE Corringham. "Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation". Blood 84, n.º 10 (15 de novembro de 1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.bloodjournal84103550.
Texto completo da fonteHo, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz e W. Hunstein. "Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma". Blood 75, n.º 1 (1 de janeiro de 1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.203.
Texto completo da fonteHo, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz e W. Hunstein. "Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma". Blood 75, n.º 1 (1 de janeiro de 1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.bloodjournal751203.
Texto completo da fontePutz, D., U. Barnas, A. Luger, G. Mayer, W. Woloszczuk e H. Graf. "Biocompatibility of High-Flux Membranes". International Journal of Artificial Organs 15, n.º 8 (agosto de 1992): 456–60. http://dx.doi.org/10.1177/039139889201500802.
Texto completo da fonteHamed, Nahla, Nahla Farahat, Manal El Sorady, Dalia Nafee e Sherine Barakat. "Clinical significance of sCD86 levels in patients with acute myelogenous leukemia". Alexandria Journal of Medicine 47, n.º 1 (1 de março de 2011): 25–30. http://dx.doi.org/10.1016/j.ajme.2011.04.002.
Texto completo da fonteNascimento, Catarina, Andreia Gameiro, Jorge Correia, João Ferreira e Fernando Ferreira. "The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications". Cells 11, n.º 16 (18 de agosto de 2022): 2578. http://dx.doi.org/10.3390/cells11162578.
Texto completo da fonteKashchenko, Mikhail. "INTERPRETATION OF THE MECHANISM OF THE INFLUENCE OF π0- MESONS ON THE PROCESS OF ATTRACTION OF NUCLEI". Hadronic Journal 47, n.º 1 (1 de março de 2024): 89–94. http://dx.doi.org/10.29083/hj.47.01.2024/sc89.
Texto completo da fonteDíaz García, Elena, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz Hernández et al. "Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation". IBJ Plus 1, s5 (3 de junho de 2022): 1. http://dx.doi.org/10.24217/2531-0151.22v1s5.00001.
Texto completo da fonteBarlan, Işil B., M. M. Başaran, M. Bakir, F. Tükenmez e Nural Bekiroğlu. "Serum TNF-α, sCD8 and sIL-2R levels in childhood tuberculosis". Infection 23, n.º 4 (julho de 1995): 237–39. http://dx.doi.org/10.1007/bf01781205.
Texto completo da fontePujalte, J. M. "Présence pulmonaire de sCD87 au cours du syndrome de détresse respiratoire aiguë (SDRA)". Revue des Maladies Respiratoires 21, n.º 6 (dezembro de 2004): 1212. http://dx.doi.org/10.1016/s0761-8425(04)71619-8.
Texto completo da fonteSpathas, Nikolaos, Anna C. Goussia, Georgia-Angeliki Koliou, Helen Gogas, Flora Zagouri, Anna Batistatou, Antonia V. Charchanti et al. "Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study". Cancers 14, n.º 22 (16 de novembro de 2022): 5635. http://dx.doi.org/10.3390/cancers14225635.
Texto completo da fonteOzkorucu, Duygu, Nuran Cetin, Nadide Melike Sav e Bilal Yildiz. "Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome". International Urology and Nephrology 48, n.º 7 (27 de fevereiro de 2016): 1187–96. http://dx.doi.org/10.1007/s11255-016-1249-4.
Texto completo da fonteSanders, David E., Mark S. Stave, Leslie S. Perkins e Andrew E. DePristo. "SCT89: a computer code for atomic and molecular scattering from clean and adsorbate covered surfaces". Computer Physics Communications 70, n.º 3 (julho de 1992): 579–608. http://dx.doi.org/10.1016/0010-4655(92)90118-i.
Texto completo da fonteDe Rie, MA, IM Zonneveld, L. Witkamp, RA Van Lier, TA Out e JD Bos. "Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1." Acta Dermato-Venereologica 76, n.º 5 (1 de setembro de 1996): 357–60. http://dx.doi.org/10.2340/0001555576357360.
Texto completo da fonteKuryliszyn-Moskal, A., K. Bemacka e O. Bielecka. "Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis". Immunology Letters 56 (maio de 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)86296-7.
Texto completo da fonteKuryliszyn-Moskal, A. "Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis". Immunology Letters 56, n.º 1-3 (maio de 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)88134-5.
Texto completo da fonteBrasoveanu, L. I., E. Fonsatti, A. Visintin, M. Pavlovic, I. Cattarossi, F. Colizzi, A. Gasparollo et al. "Melanoma cells constitutively release an anchor-positive soluble protectin (sCD59) that retains functional activities in complement-mediated cytotoxicity". Melanoma Research 7, Supplement 1 (junho de 1997): S10. http://dx.doi.org/10.1097/00008390-199706001-00034.
Texto completo da fonteKim, Han-Soo, Dimitrios Degiannis, Jana Raskova e Karel Raska. "Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: Correlation with proliferative responses". Clinical Immunology and Immunopathology 60, n.º 1 (julho de 1991): 27–39. http://dx.doi.org/10.1016/0090-1229(91)90109-n.
Texto completo da fontevan der Merwe, P. Anton, Dale L. Bodian, Susan Daenke, Peter Linsley e Simon J. Davis. "CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics". Journal of Experimental Medicine 185, n.º 3 (3 de fevereiro de 1997): 393–404. http://dx.doi.org/10.1084/jem.185.3.393.
Texto completo da fonteCaruso, C., G. Candore, D. Cigna, S. Tripi, G. Di Gaetano, G. Migneco, G. Montalto, I. Ruggieri e A. Notarbartolo. "Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis". Mediators of Inflammation 3, n.º 3 (1994): 185–87. http://dx.doi.org/10.1155/s0962935194000256.
Texto completo da fonteMartens, A., RAJ Janssen, DTh Sleijfer, AA Heijn, NH Mulder, TH The e L. de Leij. "Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response". British Journal of Cancer 67, n.º 5 (maio de 1993): 1118–21. http://dx.doi.org/10.1038/bjc.1993.205.
Texto completo da fonte